Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymer conjugates. Pharmacokinetic considerations for design and development

R Duncan1, F Spreafico

  • 1Pharmacia Farmitalia Carlo Erba srl, Milan, Italy.

Clinical Pharmacokinetics
|October 1, 1994
PubMed
Summary

Polymer conjugates, including polymer-protein and polymer-drug types, offer enhanced drug delivery by altering biodistribution and reducing degradation. Further clinical pharmacokinetic studies are needed to optimize their use in medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in emergency and primary care use after adding virtual physicians to HealthLink BC's 8-1-1 program.

NPJ digital medicine·2025
Same author

Assessment of Clinical and Neurological Alterations Before Radiation Therapy in Children With Malignant Brain Tumours.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Physical therapy in patients with Parkinson's disease treated with Deep Brain Stimulation: a Delphi panel study.

medRxiv : the preprint server for health sciences·2024
Same author

Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study.

Journal of endocrinological investigation·2021
Same author

Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Two Consecutive Invasive Surgeries Utilizing Zymogen Protein C (ZPC) That Enhanced Patient Safety and Reduced Costs.

Advances in experimental medicine and biology·2021

Area of Science:

  • Bioconjugate Chemistry
  • Pharmacology
  • Drug Delivery Systems

Background:

  • Soluble polymer conjugates are a recent addition to clinical practice, categorized into polymer-protein and polymer-drug types.
  • Polymer conjugation modifies drug properties like biodistribution, metabolism, and elimination.
  • Polymer-protein conjugates show prolonged plasma half-life, reduced degradation, and decreased immunogenicity.

Purpose of the Study:

  • To review the theoretical basis for polymer conjugation in drug delivery.
  • To discuss the current clinical pharmacokinetic data for polymer conjugates.
  • To highlight the need for more clinical pharmacokinetic studies to optimize conjugate design and clinical protocols.

Main Methods:

  • Review of existing literature on polymer conjugates.

Related Experiment Videos

  • Analysis of pharmacokinetic data from clinical studies.
  • Theoretical discussion of the rationale behind polymer conjugation.

    • Main Results:

    • Polymer conjugation can significantly increase protein plasma elimination half-life (5- to 500-fold).
    • Cellular uptake of polymer-bound drugs is primarily via endocytosis, allowing modification of organ and subcellular distribution.
    • Current clinical pharmacokinetic data for polymer conjugates is limited.

    Conclusions:

    • Polymer conjugation offers a strategy to improve drug delivery, targeting, and reduce toxicity.
    • Extensive clinical pharmacokinetic studies are essential for validating models and optimizing the clinical application of polymer conjugates.
    • Further research is needed to fully realize the potential of polymer conjugates in therapeutic interventions.